SK bioscience, a global innovative vaccine and biotech company committed to promoting human healt...

-CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; ...

- Global experts continue to join SK bioscience, while its U.S. corporate entity is being establishe...

Company submitted an application for CMA of SKYCovione™ to MHRA and EMA, followed by EUL to WHO. ...

· 609,000 doses of advance purchased SKYCovione™ will be sequentially supplied based on the vacci...

[16 August 2022] SK bioscience announced that Tae Won Chey, Chairman of SK group, Chang Won (Andr...

SK extends the vaccination age of Nuvaxovid to 12 to 17-year-oldsThe recombinant protein-based vacci...

SK bioscience will accelerate to apply for emergency use listing (EUL) to the World Health Organiz...

If approved, SK bioscience will accelerate to apply for emergency use listing (EUL) to the World Hea...

SK bioscience and Novavax agreement also includes production of the Novavax COVID-19 vaccine in pre...

Neutralizing antibody titres against Omicron variant BA.1 after a booster dose of SKYCovione™ were ...

SKYCovione™ will be ready to enter into domestic vaccine markets after passing the national lot rel...